Strategic US Oncology Launch Leader

Incyte Corporation; Chadds Ford Township (PA); On-site; USD 150,000 - 210,000; Full time

Job summary

Incyte Corporation seeks an experienced US Launch Lead for a specific solid tumor asset expected to launch in about 18 months. You will translate asset strategy into an integrated US launch plan, ensuring cross-functional alignment and strong in-market execution at launch.

You will bridge R&D, Global, and US Commercial to shape asset strategy, market development, and organizational readiness for long-term value and expansion into new disease areas.

Qualifications

• 10+ years of progressive oncology commercial experience required, including in-line marketing, brand strategy, or commercialization experience.
• Launch planning or launch readiness experience required.
• New product planning experience preferred.
• Experience partnering with Market Access and/or Insights & Analytics preferred.

Responsibilities

• Lead development and refinement of the integrated US launch plan for one solid tumor asset and align priorities, milestones, risks, and decision points across the launch window.
• Own creation of the US promotional messaging platform and launch strategy, including core brand positioning, value proposition, and claims hierarchy.
• Establish launch objectives, metrics, dashboards, forecast assumptions, and governance for post-launch performance tracking.
• Chair or co-lead the US cross-functional launch team, driving ownership, decision-making and escalation.
• Lead near-term market readiness activities including competitive response planning, payer input, and field-force preparation.

Skills

Launch leadership

Oncology expertise

Clinical-commercial integration

US promotional strategy

Launch analytics

Matrix leadership

Strong communication

Education

Bachelor’s degree

MBA or advanced degree

Job description

Incyte Corporation seeks an experienced US Launch Lead for a specific solid tumor asset expected to launch in about 18 months. You will translate asset strategy into an integrated US launch plan, ensuring cross-functional alignment and strong in-market execution at launch.

You will bridge R&D, Global, and US Commercial to shape asset strategy, market development, and organizational readiness for long-term value and expansion into new disease areas.